3/5
04:33 pm
cdna
CareDx Announces VANTx™, an AI-Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets [Yahoo! Finance]
Low
Report
CareDx Announces VANTx™, an AI-Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets [Yahoo! Finance]
3/5
04:01 pm
cdna
CareDx Announces VANTx™, an AI-Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
Low
Report
CareDx Announces VANTx™, an AI-Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
2/28
06:09 pm
cdna
CareDx (CDNA) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d)".
Low
Report
CareDx (CDNA) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d)".
2/27
04:01 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/25
07:05 pm
cdna
CareDx (CDNA) had its "buy" rating reaffirmed by BTIG Research.
Medium
Report
CareDx (CDNA) had its "buy" rating reaffirmed by BTIG Research.
2/25
10:24 am
cdna
CareDx (CDNA) had its price target raised by Wells Fargo & Company from $18.00 to $21.00. They now have an "equal weight" rating on the stock.
Medium
Report
CareDx (CDNA) had its price target raised by Wells Fargo & Company from $18.00 to $21.00. They now have an "equal weight" rating on the stock.
2/24
11:29 pm
cdna
CareDx Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
CareDx Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
09:03 pm
cdna
CareDx (CDNA) Q4 Earnings Miss Estimates [Yahoo! Finance]
Medium
Report
CareDx (CDNA) Q4 Earnings Miss Estimates [Yahoo! Finance]
2/24
06:47 pm
cdna
CareDx (CDNA) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
CareDx (CDNA) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/24
05:15 pm
cdna
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
Medium
Report
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
2/24
04:32 pm
cdna
CareDx: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
CareDx: Q4 Earnings Snapshot [Yahoo! Finance]
2/24
04:01 pm
cdna
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
Low
Report
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results
2/18
08:00 am
cdna
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
Low
Report
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
2/14
07:09 pm
cdna
Assessing CareDx (CDNA) Valuation After Positive AlloHeme Clinical Validation Results [Yahoo! Finance]
Low
Report
Assessing CareDx (CDNA) Valuation After Positive AlloHeme Clinical Validation Results [Yahoo! Finance]
2/12
04:27 pm
cdna
CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript [Seeking Alpha]
Low
Report
CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript [Seeking Alpha]
2/12
07:05 am
cdna
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI-Powered NGS Surveillance Solution for AML and MDS Post-Cell Therapy
Medium
Report
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI-Powered NGS Surveillance Solution for AML and MDS Post-Cell Therapy
2/10
04:01 pm
cdna
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Medium
Report
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
2/3
07:23 am
cdna
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings [Yahoo! Finance]
Low
Report
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings [Yahoo! Finance]
2/3
07:05 am
cdna
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
Low
Report
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
2/1
03:42 am
cdna
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 [Yahoo! Finance]
Low
Report
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 [Yahoo! Finance]
1/31
05:22 am
cdna
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? [Yahoo! Finance]
Low
Report
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? [Yahoo! Finance]
1/30
10:38 am
cdna
CareDx President and CEO Sells 19,000 Shares for $412,000 [Yahoo! Finance]
Low
Report
CareDx President and CEO Sells 19,000 Shares for $412,000 [Yahoo! Finance]
1/27
05:16 pm
cdna
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference [Yahoo! Finance]
Medium
Report
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference [Yahoo! Finance]
1/27
04:05 pm
cdna
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Low
Report
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
1/12
07:20 am
cdna
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]